Insider Trades65 trades
| Date↓ | Side | Ticker↕ | Insider↕ | Role↕ | Shares↕ | Price↕ | Mkt Cap↕ | 52W High↕ | 52W Low↕ | Value↕ | % Chg↕ | Rule↕ | AI View↕ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $86.47 | $10.2B | -0.01% | +281.66% | $832.2K | -0.30% | 10b5-1 | Stalk |
| Jul 24, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 15,000 | $134.28 | $10.2B | -0.01% | +281.66% | $2.0M | -8.65% | — | Stalk |
| Jul 14, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 8,000 | $133.96 | $10.2B | -0.01% | +281.66% | $1.1M | -4.50% | — | Stalk |
| Jul 8, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 95,046 | $28.12 | $10.2B | -0.01% | +281.66% | $2.7M | -4.72% | 10b5-1 | Stalk |
| Jul 1, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $85.65 | $10.2B | -0.01% | +281.66% | $824.4K | -0.29% | 10b5-1 | Stalk |
| Jun 22, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 26,400 | $132.60 | $10.2B | -0.01% | +281.66% | $3.5M | -12.84% | 10b5-1 | Stalk |
| Jun 22, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 80,000 | $132.54 | $10.2B | -0.01% | +281.66% | $10.6M | -7.30% | 10b5-1 | Stalk |
| Jun 10, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $83.38 | $10.2B | -0.01% | +281.66% | $1.7M | -0.30% | 10b5-1 | Stalk |
| Jun 3, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $54.77 | $10.2B | -0.01% | +281.66% | $527.2K | -0.26% | 10b5-1 | Stalk |
| May 13, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $82.09 | $10.2B | -0.01% | +281.66% | $1.6M | -0.89% | 10b5-1 | Stalk |
| May 6, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $57.88 | $10.2B | -0.01% | +281.66% | $557.1K | -0.18% | 10b5-1 | Stalk |
| May 1, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $82.04 | $10.2B | -0.01% | +281.66% | $164.1K | -0.38% | 10b5-1 | Stalk |
| Apr 16, 2026 | Buy | APGE | Michael Thomas Henderson | Chief Executive Officer | 3,000 | $22.86 | $10.2B | -0.01% | +281.66% | $68.6K | +0.20% | — | Stalk |
| Apr 16, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $90.00 | $10.2B | -0.01% | +281.66% | $180.0K | -1.13% | 10b5-1 | Stalk |
| Apr 8, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $82.58 | $10.2B | -0.01% | +281.66% | $1.7M | -0.58% | 10b5-1 | Stalk |
| Apr 1, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $85.01 | $10.2B | -0.01% | +281.66% | $170.0K | -0.56% | 10b5-1 | Stalk |
| Apr 1, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $58.28 | $10.2B | -0.01% | +281.66% | $560.9K | -0.14% | 10b5-1 | Stalk |
| Mar 25, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $85.00 | $10.2B | -0.01% | +281.66% | $170.0K | -1.10% | 10b5-1 | Stalk |
| Mar 11, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $74.78 | $10.2B | -0.01% | +281.66% | $1.5M | -0.57% | 10b5-1 | Stalk |
| Mar 4, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $50.40 | $10.2B | -0.01% | +281.66% | $485.1K | -0.14% | 10b5-1 | Stalk |
| Mar 2, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $70.22 | $10.2B | -0.01% | +281.66% | $140.4K | -0.27% | 10b5-1 | Stalk |
| Feb 11, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $63.35 | $10.2B | -0.01% | +281.66% | $1.3M | -0.56% | 10b5-1 | Stalk |
| Feb 4, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 9,625 | $47.39 | $10.2B | -0.01% | +281.66% | $456.2K | -0.10% | 10b5-1 | Stalk |
| Feb 2, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $65.81 | $10.2B | -0.01% | +281.66% | $131.6K | -0.36% | 10b5-1 | Stalk |
| Jan 14, 2026 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $81.11 | $10.2B | -0.01% | +281.66% | $1.6M | -0.28% | 10b5-1 | Stalk |
| Jan 7, 2026 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 32,725 | $54.28 | $10.2B | -0.01% | +281.66% | $1.8M | -0.38% | 10b5-1 | Stalk |
| Jan 2, 2026 | Sell | APGE | Jane Henderson | Chief Financial Officer | 8,000 | $76.14 | $10.2B | -0.01% | +281.66% | $609.1K | -1.22% | 10b5-1 | Stalk |
| Dec 19, 2025 | Sell | APGE | Jane Henderson | Chief Financial Officer | 1,500 | $80.00 | $10.2B | -0.01% | +281.66% | $120.0K | -0.77% | 10b5-1 | Stalk |
| Dec 10, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $75.38 | $10.2B | -0.01% | +281.66% | $1.5M | -0.54% | 10b5-1 | Stalk |
| Dec 4, 2025 | Sell | APGE | Jane Henderson | Chief Financial Officer | 1,500 | $75.00 | $10.2B | -0.01% | +281.66% | $112.5K | -0.76% | 10b5-1 | Stalk |
| Dec 4, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 10,900 | $75.00 | $10.2B | -0.01% | +281.66% | $817.5K | -3.87% | 10b5-1 | Stalk |
| Dec 4, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 40,000 | $75.01 | $10.2B | -0.01% | +281.66% | $3.0M | -3.14% | 10b5-1 | Stalk |
| Nov 25, 2025 | Sell | APGE | Jane Henderson | Chief Financial Officer | 1,500 | $70.00 | $10.2B | -0.01% | +281.66% | $105.0K | -0.76% | 10b5-1 | Stalk |
| Nov 14, 2025 | Sell | APGE | Jane Henderson | Chief Financial Officer | 2,000 | $65.00 | $10.2B | -0.01% | +281.66% | $130.0K | -1.00% | 10b5-1 | Stalk |
| Nov 13, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 20,000 | $63.01 | $10.2B | -0.01% | +281.66% | $1.3M | -0.39% | 10b5-1 | Stalk |
| Nov 11, 2025 | Sell | APGE | Jane Henderson | Chief Financial Officer | 1,000 | $60.00 | $10.2B | -0.01% | +281.66% | $60.0K | -0.50% | 10b5-1 | Stalk |
| Nov 5, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 18,845 | $41.29 | $10.2B | -0.01% | +281.66% | $778.2K | -0.17% | 10b5-1 | Stalk |
| Oct 1, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 7,495 | $34.41 | $10.2B | -0.01% | +281.66% | $257.9K | -0.37% | 10b5-1 | Stalk |
| Sep 3, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 2,725 | $37.87 | $10.2B | -0.01% | +281.66% | $103.2K | -0.58% | 10b5-1 | Stalk |
| Aug 6, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 2,725 | $37.78 | $10.2B | -0.01% | +281.66% | $103.0K | -1.14% | 10b5-1 | Stalk |
| Jul 2, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 17,455 | $35.71 | $10.2B | -0.01% | +281.66% | $623.3K | -0.24% | 10b5-1 | Stalk |
| Jun 4, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 2,725 | $36.96 | $10.2B | -0.01% | +281.66% | $100.7K | -1.11% | 10b5-1 | Stalk |
| May 7, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 2,725 | $35.75 | $10.2B | -0.01% | +281.66% | $97.4K | -1.10% | 10b5-1 | Stalk |
| Apr 2, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 3,860 | $36.22 | $10.2B | -0.01% | +281.66% | $139.8K | -0.52% | 10b5-1 | Stalk |
| Mar 5, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 1,590 | $30.48 | $10.2B | -0.01% | +281.66% | $48.5K | -0.63% | 10b5-1 | Stalk |
| Mar 5, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 10,000 | $30.15 | $10.2B | -0.01% | +281.66% | $301.5K | -0.38% | 10b5-1 | Stalk |
| Feb 5, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 4,315 | $37.40 | $10.2B | -0.01% | +281.66% | $161.4K | -0.40% | 10b5-1 | Stalk |
| Feb 5, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 15,000 | $40.58 | $10.2B | -0.01% | +281.66% | $608.7K | -1.14% | 10b5-1 | Stalk |
| Jan 31, 2025 | Buy | APGE | Michael Thomas Henderson | Chief Executive Officer | 8,500 | $22.86 | $10.2B | -0.01% | +281.66% | $194.3K | +0.50% | — | Stalk |
| Jan 8, 2025 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 15,000 | $48.85 | $10.2B | -0.01% | +281.66% | $732.7K | -0.57% | 10b5-1 | Stalk |
| Jan 2, 2025 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 5,445 | $40.92 | $10.2B | -0.01% | +281.66% | $222.8K | -0.23% | 10b5-1 | Stalk |
| Dec 11, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 6,355 | $41.36 | $10.2B | -0.01% | +281.66% | $262.9K | -0.29% | 10b5-1 | Stalk |
| Dec 4, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 6,665 | $46.07 | $10.2B | -0.01% | +281.66% | $307.1K | -2.49% | 10b5-1 | Stalk |
| Dec 4, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 15,000 | $46.58 | $10.2B | -0.01% | +281.66% | $698.7K | -0.56% | 10b5-1 | Stalk |
| Nov 6, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 6,665 | $59.12 | $10.2B | -0.01% | +281.66% | $394.0K | -1.23% | 10b5-1 | Stalk |
| Nov 6, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 15,000 | $59.22 | $10.2B | -0.01% | +281.66% | $888.3K | -0.56% | 10b5-1 | Stalk |
| Oct 2, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 6,665 | $56.26 | $10.2B | -0.01% | +281.66% | $375.0K | -1.20% | 10b5-1 | Stalk |
| Oct 2, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 40,000 | $56.23 | $10.2B | -0.01% | +281.66% | $2.2M | -1.45% | 10b5-1 | Stalk |
| Sep 4, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 6,665 | $47.56 | $10.2B | -0.01% | +281.66% | $317.0K | -1.17% | 10b5-1 | Stalk |
| Sep 4, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 40,000 | $47.62 | $10.2B | -0.01% | +281.66% | $1.9M | -1.41% | 10b5-1 | Stalk |
| Aug 23, 2024 | Sell | APGE | Jane Henderson | Chief Financial Officer | 6,000 | $48.26 | $10.2B | -0.01% | +281.66% | $289.6K | -2.90% | — | Stalk |
| Aug 7, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 7,335 | $40.67 | $10.2B | -0.01% | +281.66% | $298.3K | -0.84% | 10b5-1 | Stalk |
| Aug 7, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 40,000 | $40.62 | $10.2B | -0.01% | +281.66% | $1.6M | -0.92% | 10b5-1 | Stalk |
| Jul 5, 2024 | Sell | APGE | Michael Thomas Henderson | Chief Executive Officer | 15,000 | $37.26 | $10.2B | -0.01% | +281.66% | $558.9K | -1.01% | 10b5-1 | Stalk |
| Jul 3, 2024 | Sell | APGE | Carl Dambkowski | Chief Medical Officer | 5,995 | $37.60 | $10.2B | -0.01% | +281.66% | $225.4K | -1.00% | 10b5-1 | Stalk |